Adrian Lim, LLB / BCom, is CEO and co-founder of Ananda Immunotherapies. Adrian has international experience as an early-stage venture builder and in commercial strategy. Adrian previously co-founded another clinical stage biotech that was focused on the metabolic disease space utilizing a peptide-based approach. He previously worked with LEK, an international management consulting firm with a strong practice in life sciences and healthcare, in the firm’s offices in Australia, the US and Japan.